Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: BASi | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: BASi

Service revenue in the quarter down 22%

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BASi
 
4Q Revenues: $5.0 million (-22%)

4Q Loss: $721,000 (loss of $389,000 4Q14)

FY Revenues: $22.7 million (-8%)

FY Earnings: $1.1 million (loss of $1.1 million FY14)

Comments: Service revenue in the quarter was down 22% to $3.8 million, negatively impacted by fewer bioequivalence studies and fewer samples received and analyzed. Service revenue for the year was down 7% to $17.8 million. Product revenue in the quarter was $1.1 million, down 25%, and $4.9 million for the year, down 10%, impacted by lower sales of analytical instruments relating to Culex..

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics